Your browser doesn't support javascript.
loading
Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial.
Sumiyoshi, Takayuki; Wang, Xiaofei; Warner, Evan W; Sboner, Andrea; Annala, Matti; Sigouros, Michael; Beja, Kevin; Mizuno, Kei; Ku, Shengyu; Fazli, Ladan; Eastham, James; Taplin, Mary-Ellen; Simko, Jeffrey; Halabi, Susan; Morris, Michael J; Gleave, Martin E; Wyatt, Alexander W; Beltran, Himisha.
Affiliation
  • Sumiyoshi T; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Wang X; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Warner EW; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Sboner A; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Annala M; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Sigouros M; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Beja K; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Mizuno K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Ku S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Fazli L; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Eastham J; Urology Service at the Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Simko J; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.
  • Halabi S; Department of Biostatistics and Bioinformatics, Duke Cancer Institute, Durham, NC, USA.
  • Morris MJ; Department of Genitourinary Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gleave ME; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Wyatt AW; Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
J Natl Cancer Inst ; 116(1): 115-126, 2024 01 10.
Article in En | MEDLINE | ID: mdl-37676819
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Limits: Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2024 Document type: Article Affiliation country: Canada Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms Limits: Humans / Male Language: En Journal: J Natl Cancer Inst Year: 2024 Document type: Article Affiliation country: Canada Country of publication: United States